Skip to main content
Message Font: Serif | Sans-Serif
 
No. of Recommendations: 0
Fuma -- thanks for your background thoughts on NASH.

I am in a Canadian company Theratechnologies (OTC: THERF) which is already treating HIV patients with fatty liver with EGRIFTA containing Tesamorelin so should have a decent safety profile.

This week they announced good results in trying to extend the label on Tesamorelin to NASH.

https://www.globenewswire.com/news-release/2019/06/17/186968...

The stock is down since the announcement so maybe the market sees similar business case as you do.

However Tesamorelin is not why I'm in THERF, I am hoping for commercial success of their HIV drug http://trogarzo.com/.

I don't have the deep background into pharma companies that you do. Have you ever looked at Theratechnologies?
Print the post  

Announcements

What was Your Dumbest Investment?
Share it with us -- and learn from others' stories of flubs.
When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.